Wedbush Maintains Outperform on Pharvaris, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico has maintained an 'Outperform' rating on Pharvaris (NASDAQ:PHVS), but lowered the price target from $27 to $24.
November 03, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pharvaris's price target has been lowered from $27 to $24 by Wedbush, although the 'Outperform' rating is maintained.
The lowering of the price target by Wedbush could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100